Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Large-scale testing (Phase 3)Active Not RecruitingNCT02881320
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Who this might be right for
HIV-1 Infection
Gilead Sciences 177
Large-scale testing (Phase 3)Study completedNCT04618198
What this trial is testing

Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

Who this might be right for
TuberculosisHIV I InfectionSepsis
University of Virginia 437
Early research (Phase 1)Study completedNCT00705926
What this trial is testing

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

Who this might be right for
HIV Infections
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT01302847
What this trial is testing

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 181
Large-scale testing (Phase 3)Study completedNCT00398684
What this trial is testing

Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand

Who this might be right for
HIV InfectionsPregnancy
Institut de Recherche pour le Developpement 1,792
Testing effectiveness (Phase 2)Study completedNCT00951015
What this trial is testing

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 208
Early research (Phase 1)Study completedNCT05604209
What this trial is testing

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART

Who this might be right for
HIV VaccineHIV-1-infection
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT00000925
What this trial is testing

Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Active Not RecruitingNCT05705349
What this trial is testing

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 537
Testing effectiveness (Phase 2)Study completedNCT05330143
What this trial is testing

Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV

Who this might be right for
HIV-1-infectionHIV InfectionsPD-L1 Gene Mutation
Ascletis Pharmaceuticals Co., Ltd. 19
Large-scale testing (Phase 3)UnknownNCT00006208
What this trial is testing

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00648817
What this trial is testing

Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers

Who this might be right for
HIV Infections
Gilead Sciences 8
Large-scale testing (Phase 3)Study completedNCT00002199
What this trial is testing

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Who this might be right for
HIV Infections
Glaxo Wellcome 550
Large-scale testing (Phase 3)UnknownNCT05154747
What this trial is testing

Long-Acting Treatment in Adolescents (LATA)

Who this might be right for
HivHIV InfectionsHIV-1-infection+1 more
University College, London 476
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Not applicableLooking for participantsNCT07643948
What this trial is testing

Impacts of HIV Treatment Regimens on Archived Drug Resistance

Who this might be right for
HIV -1 InfectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong 420
Not applicableUnknownNCT00069485
What this trial is testing

Resistance to HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableActive Not RecruitingNCT06358885
What this trial is testing

IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention

Who this might be right for
HIV-1-infectionUnhealthy Alcohol Use
University of North Carolina, Chapel Hill 3,234
Next Page